Clinical Trials Browser

Terminated × Esophageal Neoplasms × Epirubicin × Clear all

NCT02358863 2018-09-06

mEGA

Phase NA Terminated

13 enrolled 6 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT00130936 2016-02-15

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Phase 1/2 Terminated

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms